This report contains market size and forecasts of Alectinib in global, including the following market information:
Global Alectinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Alectinib Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Alectinib companies in 2021 (%)
The global Alectinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
150mg*140 Capsules Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alectinib include Roche and Everest Pharmaceuticals etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alectinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alectinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Alectinib Market Segment Percentages, by Type, 2021 (%)
150mg*140 Capsules
150mg*28 Capsules
20mg*1 Capsule
40mg*1 Capsule
150mg*26 Capsules
Global Alectinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Alectinib Market Segment Percentages, by Application, 2021 (%)
Unresectable NSCLC
Advanced NSCLC
Recurrent NSCLC
Other
Global Alectinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Alectinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alectinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Alectinib revenues share in global market, 2021 (%)
Key companies Alectinib sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Alectinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Everest Pharmaceuticals